Supplements
Oculis Begins Registrational Trial for Precision Dry Eye Biologic
The phase 3 trial tests a precision medicine approach to DED — a category where nutraceutical and Rx crossover is inten…
Supplements 17 stories
Supplements
NIS4 Biomarker Tech Powers Labcorp Direct-Access MASH Test
Direct-to-consumer lab access expands the clinical addressability of metabolic liver disease — a condition increasingly…
Supplements
Optimi Health Secures Ibogaine Supply for Finished Drug Development
A recent executive order places ibogaine among prioritized psychedelic compounds, signaling a potential regulatory path…
Supplements
Inhaled Insulin Afrezza Posts New Data Across Pediatric and AID Use
New data across three high-complexity populations could reshape how formulators and clinicians think about insulin-deli…
Supplements
Teva Launches Aflibercept Biosimilar in Europe
The Eylea® reference biologic biosimilar adds to a growing European pipeline as manufacturers push for broader access t…